Recurrent 2,8-Dihydroxyadenine Nephropathy: A Rare but Preventable Cause of Renal Allograft Failure

Autor: Zaidan, M., Palsson, R., Merieau, E., Cornec-Le Gall, E., Garstka, A., Maggiore, U., Deteix, P., Battista, M., Gagné, E.-R., Ceballos-Picot, I., Duong Van Huyen, J.-P., Legendre, C., Daudon, M., Edvardsson, V.O., Knebelmann, B. ^*

Publikováno v: In American Journal of Transplantation November 2014 14(11):2623-2632

Cell Therapy With Autologous Tolerogenic Dendritic Cells Induces Allograft Tolerance Through Interferon-Gamma and Epstein-Barr Virus-Induced Gene 3

Autor: Hill, M., Thebault, P., Segovia, M., Louvet, C., Bériou, G., Tilly, G., Merieau, E., Anegon, I., Chiffoleau, E., Cuturi, M.-C. ^*

Publikováno v: In American Journal of Transplantation October 2011 11(10):2036-2045

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Valganciclovir is not associated with decreased EBV infection rate in pediatric kidney transplantation.

Autor: Cheyssac E; Department of Pediatric Nephrology, Robert Debré University Hospital, APHP, Paris, France., Savadogo H; Department of Pediatrics, Pediatric Nephrology Unit, Nantes University Hospital, Nantes, France., Lagoutte N; Department of Pediatrics, Pediatric Nephrology Unit, Nantes University Hospital, Nantes, France., Baudouin V; Department of Pediatric Nephrology, Robert Debré University Hospital, APHP, Paris, France., Charbit M; Department of Pediatric Nephrology, Necker Enfants Malades University Hospital, APHP, Paris, France., Novo R; Pediatric Nephrology Unit, Lille University Hospital, Lille, France., Sellier-Leclerc AL; Department of Pediatric Nephrology, HFME, Lyon University Hospital, Lyon, France., Fila M; Pediatric Nephrology Unit, Montpellier University Hospital, Montpellier, France., Decramer S; Pediatric Nephrology Unit, Toulouse University Hospital, Toulouse, France., Merieau E; Department of Pediatrics, Tours University Hospital, Tours, France., Zaloszyc A; Department of Pediatrics, Strasbourg University Hospital, France, Strasbourg, France., Harambat J; Pediatric Nephrology Unit, Bordeaux University Hospital, Bordeaux, France., Roussey G; Department of Pediatrics, Pediatric Nephrology Unit, Nantes University Hospital, Nantes, France.

Publikováno v: Frontiers in pediatrics [Front Pediatr] 2023 Jan 10; Vol. 10, pp. 1085101. Date of Electronic Publication: 2023 Jan 10 (Print Publication: 2022).

CLEC-1 is a death sensor that limits antigen cross-presentation by dendritic cells and represents a target for cancer immunotherapy.

Autor: Drouin M; OSE Immunotherapeutics, Nantes, France.; Nantes Université, INSERM, CHU Nantes, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000 Nantes, France., Saenz J; Nantes Université, INSERM, CHU Nantes, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000 Nantes, France., Gauttier V; OSE Immunotherapeutics, Nantes, France., Evrard B; Nantes Université, INSERM, CHU Nantes, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000 Nantes, France., Teppaz G; OSE Immunotherapeutics, Nantes, France., Pengam S; OSE Immunotherapeutics, Nantes, France., Mary C; OSE Immunotherapeutics, Nantes, France., Desselle A; OSE Immunotherapeutics, Nantes, France., Thepenier V; OSE Immunotherapeutics, Nantes, France., Wilhelm E; OSE Immunotherapeutics, Nantes, France., Merieau E; Nantes Université, INSERM, CHU Nantes, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000 Nantes, France., Ligeron C; Nantes Université, INSERM, CHU Nantes, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000 Nantes, France., Girault I; OSE Immunotherapeutics, Nantes, France., Lopez MD; Nantes Université, INSERM, CHU Nantes, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000 Nantes, France., Fourgeux C; Nantes Université, INSERM, CHU Nantes, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000 Nantes, France., Sinha D; Nantes Université, INSERM, CHU Nantes, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000 Nantes, France., Baccelli I; OSE Immunotherapeutics, Nantes, France., Moreau A; Nantes Université, INSERM, CHU Nantes, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000 Nantes, France., Louvet C; Nantes Université, INSERM, CHU Nantes, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000 Nantes, France., Josien R; Nantes Université, INSERM, CHU Nantes, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000 Nantes, France.; CHU Nantes, Nantes Université, Laboratoire d'Immunologie, CIMNA, Nantes, France., Poschmann J; Nantes Université, INSERM, CHU Nantes, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000 Nantes, France., Poirier N; OSE Immunotherapeutics, Nantes, France., Chiffoleau E; Nantes Université, INSERM, CHU Nantes, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000 Nantes, France.

Publikováno v: Science advances [Sci Adv] 2022 Nov 16; Vol. 8 (46), pp. eabo7621. Date of Electronic Publication: 2022 Nov 18.